SE303567B - - Google Patents
Info
- Publication number
- SE303567B SE303567B SE1534/60A SE153460A SE303567B SE 303567 B SE303567 B SE 303567B SE 1534/60 A SE1534/60 A SE 1534/60A SE 153460 A SE153460 A SE 153460A SE 303567 B SE303567 B SE 303567B
- Authority
- SE
- Sweden
- Prior art keywords
- solution
- buffer
- phosphate
- sodium chloride
- desalting
- Prior art date
Links
- 239000000243 solution Substances 0.000 abstract 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 4
- 229920001429 chelating resin Polymers 0.000 abstract 4
- 238000011033 desalting Methods 0.000 abstract 4
- 238000000502 dialysis Methods 0.000 abstract 4
- 238000005342 ion exchange Methods 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 4
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 239000003053 toxin Substances 0.000 abstract 3
- 231100000765 toxin Toxicity 0.000 abstract 3
- 108700012359 toxins Proteins 0.000 abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 229910019142 PO4 Inorganic materials 0.000 abstract 2
- 239000004793 Polystyrene Substances 0.000 abstract 2
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 abstract 2
- 239000003957 anion exchange resin Substances 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 239000000872 buffer Substances 0.000 abstract 2
- 239000000337 buffer salt Substances 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000012045 crude solution Substances 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 229910001410 inorganic ion Inorganic materials 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 239000010452 phosphate Substances 0.000 abstract 2
- 229920002223 polystyrene Polymers 0.000 abstract 2
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 2
- 239000012266 salt solution Substances 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- 239000012475 sodium chloride buffer Substances 0.000 abstract 2
- IBUIVNCCBFLEJL-UHFFFAOYSA-M sodium;phosphoric acid;chloride Chemical compound [Na+].[Cl-].OP(O)(O)=O IBUIVNCCBFLEJL-UHFFFAOYSA-M 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 102000016938 Catalase Human genes 0.000 abstract 1
- 108010053835 Catalase Proteins 0.000 abstract 1
- 108010065152 Coagulase Proteins 0.000 abstract 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 abstract 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108010023197 Streptokinase Proteins 0.000 abstract 1
- 108010055044 Tetanus Toxin Proteins 0.000 abstract 1
- 238000005341 cation exchange Methods 0.000 abstract 1
- 239000003729 cation exchange resin Substances 0.000 abstract 1
- 239000003228 hemolysin Substances 0.000 abstract 1
- 235000019833 protease Nutrition 0.000 abstract 1
- 229960004533 streptodornase Drugs 0.000 abstract 1
- 229960005202 streptokinase Drugs 0.000 abstract 1
- 229940118376 tetanus toxin Drugs 0.000 abstract 1
- 229960000814 tetanus toxoid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB0052137 | 1959-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE303567B true SE303567B (es) | 1968-09-02 |
Family
ID=6969786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1534/60A SE303567B (es) | 1959-02-17 | 1960-02-16 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3184394A (es) |
| GB (1) | GB938115A (es) |
| SE (1) | SE303567B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3419471A (en) * | 1965-04-19 | 1968-12-31 | Eisai Co Ltd | Preparation of albumin-free lysozyme |
| US3477912A (en) * | 1967-07-07 | 1969-11-11 | Century Lab Inc | Method of production of urokinase |
| KR890001003B1 (ko) * | 1984-07-19 | 1989-04-18 | 자이단 호오진 까가꾸 오요비 겟세이 료오호 겐뀨쇼 | Lpf-ha의 정제방법 |
| DE3439980A1 (de) * | 1984-11-02 | 1986-05-07 | Behringwerke Ag, 3550 Marburg | Verfahren zur reinigung sowie pasteurisierung von urokinase |
| US4705686A (en) * | 1986-05-09 | 1987-11-10 | American Cyanamid | Process for the preparation of acellular Bordetalla pertussis vaccine |
| US5445949A (en) * | 1992-05-19 | 1995-08-29 | Gist-Brocades N.V. | Large scale separation and purification of fermentation product |
| MX365496B (es) * | 2009-10-21 | 2019-06-05 | Revance Therapeutics Inc | Metodos y sistemas para purificar la neurotoxina botulinica no acomplejada. |
| KR101134146B1 (ko) | 2010-05-31 | 2012-04-19 | 메덱스젠 주식회사 | 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2974088A (en) * | 1958-07-18 | 1961-03-07 | Merck & Co Inc | Method of preparing growth hormone |
| US2957809A (en) * | 1959-04-13 | 1960-10-25 | Merck & Co Inc | Insulinase |
| US2997425A (en) * | 1959-05-05 | 1961-08-22 | Ortho Pharma Corp | Method of purification of streptokinase |
-
1960
- 1960-02-16 SE SE1534/60A patent/SE303567B/xx unknown
- 1960-02-17 GB GB5684/60A patent/GB938115A/en not_active Expired
-
1962
- 1962-06-04 US US199657A patent/US3184394A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB938115A (en) | 1963-09-25 |
| US3184394A (en) | 1965-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yokogawa et al. | Purification and properties of lytic enzymes from Streptomyces globisporus 1829 | |
| Stark et al. | Purification and biochemical properties of Clostridium perfringens type A enterotoxin | |
| Colvin | Synthesis of cellulose in ethanol extracts of Acetobacter xylinum | |
| SE303567B (es) | ||
| WO1991003566A1 (en) | A process for the hydrolysis of hemicellulose by immobilized enzymes and a product comprising an immobilized hemicellulolytic enzyme | |
| GB1479851A (en) | Chemical process | |
| Smart et al. | Molecular properties and sensitivity to cations of β-galactosidase from Streptococcus thermophilus with four enzyme substrates | |
| Hill | Purification and properties of streptococcal hyaluronate lyase | |
| ES337291A1 (es) | Procedimiento para la produccion de lisozima a partir de clara de huevo. | |
| Iizuka et al. | Studies on the xylanase from Streptomyces Part I. Purification and some properties of xylanase from Streptomyces xylophagus nov. sp | |
| Schwab | AN INTRACELLULAR HEMOLYSIN OF GROUP A STREPTOCOCCI II: Comparative Properties of Intracellular Hemolysin, Streptolysin S′, and Streptolysin O | |
| GB1178011A (en) | A method of Recovering Lysine from Fermentation Broth | |
| IE40935B1 (en) | Method of extracting enzymes from aqueous solutions | |
| Umezawa et al. | AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE III A NEW PHOSPHOTRANSFERASE RESISTANCE MECHANISM | |
| Bergdoll et al. | The recovery of staphylococcal enterotoxin from bacterial culture supernatants by ion exchange | |
| US3723252A (en) | Method for removing pyrogenic substances out of urokinase | |
| Koburger et al. | Identification of substances in milk cultures of Pseudomonas fluorescens which stimulate lactic starter cultures | |
| GB883549A (en) | Improvements in and relating to the purification of antihaemophilic globulin | |
| GB1107078A (en) | Recovery of acidic amino acids | |
| Eady et al. | Production and partial purification of a peptide antibiotic from Staphylococcus epidermidis | |
| GB966672A (en) | Process for the manufacture of streptokinase | |
| GB958048A (en) | Process for removal of radionuclides from milk | |
| SU1699162A1 (ru) | Способ выделения тилозина | |
| GB1295376A (es) | ||
| GB1404399A (en) | Ion exchange regeneration process |